Compare RUN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUN | PBH |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2015 | 2004 |
| Metric | RUN | PBH |
|---|---|---|
| Price | $14.16 | $50.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 3 |
| Target Price | $18.80 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 8.5M | 443.5K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.35 | 2.88 |
| EPS | 0.62 | ★ 2.78 |
| Revenue | $858,578,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $2.81 | N/A |
| Revenue Next Year | $4.54 | $4.31 |
| P/E Ratio | $23.40 | ★ $18.07 |
| Revenue Growth | 12.97 | ★ 36.77 |
| 52 Week Low | $5.38 | $49.28 |
| 52 Week High | $22.44 | $87.09 |
| Indicator | RUN | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 27.57 |
| Support Level | $11.84 | N/A |
| Resistance Level | $14.72 | $62.91 |
| Average True Range (ATR) | 0.82 | 2.25 |
| MACD | 0.25 | -0.49 |
| Stochastic Oscillator | 60.28 | 12.62 |
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.